HOME >> BIOLOGY >> NEWS
Vion's TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Genetically Modified Salmonella Lack Ability to Induce TNF-Alpha and Cause Sepsis According to Nature Biotechnology Publication

NEW HAVEN, CT (December 29, 1998): New research demonstrates that genetic modification of a cell wall component of tumor-targeting Salmonella bacteria can greatly reduce the bacteria's potential for virulence and ability to cause septic shock, announced Vion Pharmaceuticals, Inc. (Nasdaq: VION). Vion is developing the modified bacteria, the heart of the company's TAPET technology, as vectors for the targeted, systemic delivery of anti-cancer agents to tumors throughout the body.

A publication detailing the research, entitled "Lipid A mutant Salmonella with suppressed virulence and TNF-alpha induction retain tumor-targeting in vivo," will appear in the January issue of the journal Nature Biotechnology. The article is authored by scientists at Vion and their collaborators at Yale University School of Medicine; Texas A&M University, College of Veterinary Medicine; and the University of Washington Health Sciences Center.

Vion researchers and their collaborators have previously reported the development of Salmonella that specifically target tumors over normal tissues. However the clinical utility of such bacteria was potentially limited by the ability of lipid A in the bacteria's cell walls to elicit the production of TNF-alpha and trigger septic shock. Now the researchers have shown that a disruption of the Salmonella msbB gene involved in the production of lipid A reduces, by 10,000 fold, the ability of the bacteria's lipid to induce TNF-alpha and cause death in animal models. At the same time, the msbB-minus Salmonella retain their tumor-targeting properties, exhibiting the ability to accumulate in tumors at ratios in excess of 1000:1 compared with normal tissues.

"Administration of these modified bacteria to mice bearing melanoma tumors results in tumors that are less than six percent the size of tumors in unt
'"/>

Contact: Joan Kureczka
JKureczka@aol.com
415-821-2413
Kureczka/Martin Associates
29-Dec-1998


Page: 1 2 3 4

Related biology news :

1. Vions TAPET® administered to first patients in Phase I human intratumoral safety trial at the Cleveland Clinic Foundation
2. Software Helps Decipher Genomes Of Higher Organisms
3. The Fire Down Below: Extreme Heat-Loving Organisms May Be Keys To Molecular Evolution, Origin Of Life, New Book Argues
4. Virginia Tech Scientists To Evaluate Risks Associated With Release of Recombinant Organisms
5. Transposable Elements May Have Had A Major Role In The Evolution Of Higher Organisms
6. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
7. Emory University Scientists Demonstrate New Pathway For Genetic Mutations In Everyday Cell Life
8. Wake Forest Physicians Demonstrate How Gene-Diet Interaction Affects Cholesterol Absorption
9. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus
10. Engineering Animation, Inc. Demonstrates Internet Anatomy At Visible Human Project Conference
11. Study Demonstrates High Conservation Potential Of Logged Rainforest

Post Your Comments:
(Date:6/19/2013)... most perfectly spherical large objects in nature may have ... study. It appears in ACS, journal Langmuir , ... Cartwright, Antonio G. Checa and Marthe Rousseau point out ... perhaps the most perfectly spherical, or ball-like, shape among ... a microscope. Pearls develop as nacre (mother of pearl) ...
(Date:6/19/2013)... 2013 Elsevier, a world-leading provider of scientific, technical ... announce the launch of a new open access journal, ... GeoResJ , Elsevier,s earth and planetary science journals ... journal aims to provide a forum for rapid publication ... The journal will be co-edited by six Executive Editors, ...
(Date:6/18/2013)... not a hacker lab. At Brandeis University, sophisticated ... are helping scientists understand the complex interplay between ... the virus, outer "shell" critical for replication. ... what we are finding will help researchers alter ... post-doctoral fellow Jason Perlmutter, first author of the ...
Breaking Biology News(10 mins):Computer modeling technique goes viral at Brandeis 2
(Date:6/20/2013)... MA (PRWEB) June 20, 2013 Belatrix ... firm , today released news on its latest initiative ... BSIU initiative brings together leading thought leaders, and business ... webcasts and dynamic workshops. The goal of the initiative ... to gain fresh inspiration for their product innovation efforts. ...
(Date:6/20/2013)... June 20, 2013 Confluent is a ... of medical, software, manufacturing, safety, chemical, B2B, retail and ... Charlene Nagy, Confluent’s President and CEO, they had ... engage prospects and client via social media, and direct ... and converted to new clients. “What was missing was ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 For an ... Waterless Bead Baths using metallic beads instead ... electricity, and do not require germicides. Yet, the bead ... because the bath is always ready unlike a water ... create a dry bath, which eliminates the contamination and ...
(Date:6/19/2013)... June 19, 2013  U.S. Secretary of State ... which distinguished Syngenta  scientist Mary-Dell Chilton , ... World Food Prize. The prize is the foremost international ... improving the quality, quantity or availability of food in ... laureates were recognized for "revolutionary biotechnology discoveries that unlocked ...
Breaking Biology Technology:Belatrix Software Kicks off Major Innovation Effort and Invites Innovation Expert to Share How Agile + Design Thinking Accelerate Product Innovation 2Confluent Translations Consolidates Marketing Efforts 2Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2
Cached News: